Twist Bioscience Corp
(NAS:TWST)
$
46.39
-0.69 (-1.47%)
Market Cap: 2.72 Bil
Enterprise Value: 2.52 Bil
PE Ratio: 0
PB Ratio: 5.53
GF Score: 85/100 
Twist Bioscience Corp at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023 / 11:00PM GMT
Release Date Price:
$18.55
(+0.92%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Good afternoon, everyone. Thank you for joining us. My name is Matt Sykes, life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming the management team from Twist Bioscience today, Emily Leproust, the CEO and Co-Founder; and Jim Thorburn, the CFO. Emily, Jim, thank you very much for joining us today.
Emily Marine Leproust
Twist Bioscience Corporation - Co-Founder, Chairman & CEO
Thank you.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe I think it would be helpful to maybe for you to set the stage first, talk about the most recent results and kind of what sort of trends you're seeing for the business over the course of the second half of this year.
James M. Thorburn
Twist Bioscience Corporation - CFO & Principal Accounting Officer
Yes. So in terms of recent
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers